Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
30 mars 2023 16h01 HE
|
Processa Pharmaceuticals, Inc.
Company focused on the development of Next Generation Chemotherapy drugs in 2023 and out-licensing/business development efforts for non-oncology assets.Dose escalations continue for Next Generation...
Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update
23 mars 2023 08h05 HE
|
Palisade Bio, Inc.
Phase 2 topline data readout for prevention of post-surgical abdominal adhesions on track for Q2 2023 Strong balance sheet with sufficient cash expected to fund operations into mid-2024 ...
ST. JAMES GOLD CORP. (TSXV: LORD) PROVIDES CORPORATE UPDATE
22 mars 2023 08h00 HE
|
St. James Gold Corp.
Vancouver, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to provide a corporate update and outlook for...
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
16 mars 2023 07h00 HE
|
AC Immune SA
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update Clinical-stage vaccine programs targeting amyloid-beta (Abeta), phosphorylated-Tau (pTau), and alpha-synuclein...
Veru to Present at the Oppenheimer 33rd Annual Healthcare Conference
07 mars 2023 08h30 HE
|
Veru Inc.
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...
Abaxx Provides Corporate Update and Quarterly Development Activities
22 févr. 2023 08h00 HE
|
Abaxx Technologies Inc.
TORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of...
Atlas Salt Corporate Update
21 févr. 2023 08h45 HE
|
Atlas Salt Inc.
ST. JOHN’S, Newfoundland and Labrador, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Atlas Salt (the “Company” or “Atlas” - TSXV: SALT; OTCQB: REMRF), 100% owner of North America’s premier undeveloped...
FOOTHILLS EXPLORATION, INC. ANNOUNCES CORPORATE UPDATE
27 janv. 2023 08h00 HE
|
Foothills Exploration, Inc
LOS ANGELES, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Foothills Exploration, Inc. (OTC: FTXP), including its direct and indirect subsidiaries, (“Foothills,” or the “Company”), an oil and gas exploration...
RYVYL Provides Corporate Update on Restatement of Previously Issued Financial Statements
25 janv. 2023 08h00 HE
|
RYVYL Inc.
Restatements will not impact cash, operating margins or processing volume SAN DIEGO, CA, Jan. 25, 2023 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a company that...
Ocean Biomedical Provides Corporate Update and Company Summary
24 janv. 2023 09h15 HE
|
Aesther Healthcare Acquisition Corp.
Ocean Biomedical stock is expected to trade on the Nasdaq Capital Market under ticker symbol "OCEA" PROVIDENCE, RI and NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“Ocean”), a...